Teladoc Health (NYSE:TDOC) PT Raised to $246.00 at SVB Leerink

Teladoc Health (NYSE:TDOC) had its price target upped by research analysts at SVB Leerink from $227.00 to $246.00 in a report issued on Thursday, BenzingaRatingsTable reports. The brokerage presently has an “outperform” rating on the health services provider’s stock. SVB Leerink’s price objective suggests a potential upside of 3.52% from the company’s previous close.

Other equities analysts also recently issued reports about the stock. Cowen reaffirmed a “buy” rating and set a $197.00 target price on shares of Teladoc Health in a research note on Wednesday, July 8th. ValuEngine downgraded shares of Teladoc Health from a “buy” rating to a “hold” rating in a research note on Friday, May 1st. Canaccord Genuity lifted their target price on shares of Teladoc Health from $195.00 to $255.00 and gave the stock a “buy” rating in a research note on Thursday. Cantor Fitzgerald lifted their target price on shares of Teladoc Health from $165.00 to $210.00 and gave the stock a “neutral” rating in a research note on Thursday. Finally, Royal Bank of Canada lifted their price target on shares of Teladoc Health from $200.00 to $235.00 and gave the company an “outperform” rating in a research report on Thursday. Fifteen investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $195.04.

TDOC opened at $237.63 on Thursday. The firm’s fifty day simple moving average is $207.13 and its two-hundred day simple moving average is $158.76. The company has a quick ratio of 6.14, a current ratio of 6.14 and a debt-to-equity ratio of 0.45. Teladoc Health has a 52-week low of $54.58 and a 52-week high of $240.00.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, July 29th. The health services provider reported ($0.34) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.23) by ($0.11). Teladoc Health had a negative return on equity of 10.23% and a negative net margin of 13.22%. The business had revenue of $241.03 million during the quarter, compared to analysts’ expectations of $220.49 million. During the same period in the prior year, the business posted ($0.41) earnings per share. The business’s quarterly revenue was up 85.0% on a year-over-year basis. Equities research analysts expect that Teladoc Health will post -1.41 EPS for the current year.

In other news, COO David William Sides sold 3,117 shares of Teladoc Health stock in a transaction dated Thursday, July 30th. The stock was sold at an average price of $216.67, for a total transaction of $675,360.39. Following the sale, the chief operating officer now owns 7,299 shares in the company, valued at $1,581,474.33. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William H. Frist sold 740 shares of Teladoc Health stock in a transaction dated Friday, July 24th. The stock was sold at an average price of $214.71, for a total value of $158,885.40. Following the sale, the director now owns 6,158 shares in the company, valued at approximately $1,322,184.18. The disclosure for this sale can be found here. Insiders have sold 189,977 shares of company stock worth $36,248,032 in the last quarter. Insiders own 3.42% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in TDOC. Capital World Investors grew its holdings in shares of Teladoc Health by 510.4% during the first quarter. Capital World Investors now owns 1,403,845 shares of the health services provider’s stock worth $217,610,000 after buying an additional 1,173,845 shares during the last quarter. First Trust Advisors LP lifted its position in shares of Teladoc Health by 1,406.6% in the second quarter. First Trust Advisors LP now owns 1,001,290 shares of the health services provider’s stock valued at $191,086,000 after buying an additional 934,829 shares during the last quarter. Norges Bank acquired a new stake in Teladoc Health during the 4th quarter worth approximately $51,004,000. Fred Alger Management LLC lifted its holdings in Teladoc Health by 405.7% during the 1st quarter. Fred Alger Management LLC now owns 625,931 shares of the health services provider’s stock worth $97,026,000 after purchasing an additional 502,144 shares during the last quarter. Finally, FDx Advisors Inc. increased its stake in Teladoc Health by 16,754.5% during the 1st quarter. FDx Advisors Inc. now owns 406,531 shares of the health services provider’s stock worth $575,000 after acquiring an additional 404,119 shares during the period. 97.14% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

See Also: What is an overbought condition?

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.